Executive in Residence
ClareviaCheck size: Clarevia does not publish a standard current check-size range on its official site.
Cheryl R. Blanchard, PhD invests or supports investments through Clarevia's published strategy: Back visionary healthcare entrepreneurs and breakthrough ideas that can improve patient lives, from therapeutic and device innovation to new care solutions.
Passionate teams with meaningful healthcare innovation, patient impact, scientific or clinical credibility and the integrity to build for the long term.
The current mandate is healthcare innovation; opportunities without clear patient-care relevance or credible evidence appear outside the firm's focus.
Show the unmet clinical need, scientific or product evidence, regulatory and reimbursement path, team credibility and the patient impact of the next milestone.
No writing has been linked yet. Kit can search for posts, interviews, and fund essays worth reading before outreach.
No podcast appearances are linked yet. Ask Kit to check for interviews that reveal how this investor thinks.
Quote coverage is incomplete. Kit can look for direct comments on markets, founders, and investment criteria.
Cheryl R. Blanchard, PhD is a current Executive in Residence at Clarevia, according to the firm's official roster. No prior employer, education or personal portfolio is inferred where the official source does not publish one.